AstraZeneca at EBF 2026
Nov 17–19, 2026 Barcelona, Spain ~800 attendees Website
AstraZeneca brings 2 presentations to EBF 2026 in Barcelona. Its program covers bioanalysis for new approach methodologies, including a bone marrow microphysiological system, and laser microdissection omics that link drug exposure to toxicity and disease biology.
| Organization | EBF 2026 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Pharmaceutical company with medicines in oncology, cardiovascular, renal and metabolic, respiratory and immunology, and rare diseases. | Talk Wed Nov 18 4:35–4:50pm |
Instantly find 20 buyers from AstraZeneca
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Bioanalysis Forum. Submit a correction